Sei Investments Co. Has $18.26 Million Stake in Teleflex Incorporated (NYSE:TFX)

Sei Investments Co. grew its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 23.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 102,611 shares of the medical technology company's stock after purchasing an additional 19,707 shares during the period. Sei Investments Co. owned about 0.22% of Teleflex worth $18,263,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in TFX. Janus Henderson Group PLC boosted its stake in shares of Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after buying an additional 147,147 shares during the period. State Street Corp boosted its position in Teleflex by 1.0% during the third quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock valued at $508,757,000 after purchasing an additional 21,291 shares during the last quarter. Geode Capital Management LLC boosted its position in Teleflex by 0.5% during the third quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Cooke & Bieler LP grew its stake in Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after purchasing an additional 195,150 shares in the last quarter. Finally, Magnetar Financial LLC increased its position in Teleflex by 105.2% in the 4th quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after purchasing an additional 215,961 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Remove Ads

Teleflex Stock Performance

NYSE:TFX traded up $1.93 during mid-day trading on Tuesday, hitting $140.12. 933,566 shares of the company's stock traded hands, compared to its average volume of 584,286. The firm has a market capitalization of $6.50 billion, a price-to-earnings ratio of 27.86, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The firm has a 50 day moving average of $157.48 and a two-hundred day moving average of $188.50. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping analysts' consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. On average, equities analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is currently 95.77%.

Analysts Set New Price Targets

Several brokerages recently weighed in on TFX. Raymond James lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. Wells Fargo & Company cut their price target on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Citizens Jmp lowered shares of Teleflex from an "outperform" rating to a "market perform" rating in a research note on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Finally, Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and cut their target price for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, Teleflex currently has an average rating of "Hold" and a consensus price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.